Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Validity and reliability of the Turkish version of the PRAFAB questionnaire in individuals with urinary incontinence.

Created on 08 Sep 2026

Authors

Emel Taşvuran Horata, Şeyma Betül İnce, Harun Taşkin, Osman Gerçek, Mustafa Esat İnce, Bary Berghmans

Published in

Disability and rehabilitation. Pages 1-13. Sep 08, 2026. Epub Sep 08, 2026.

Abstract

To translate and culturally adapt the Protection, Amount, Frequency, Adjustment, and Body Image (PRAFAB) questionnaire into Turkish and assess its validity and reliability.
Content validity was assessed using the item-level content validity index (I-CVI) and the scale-level content validity index based on the average method (S-CVI/Ave). Validity analyses included exploratory factor analysis (EFA), convergent validity, known-groups validity, and floor and ceiling effects. Reliability included internal consistency, corrected item-total correlations, and test-retest reliability using a two-way mixed-effects intraclass correlation coefficient (ICC).
The study included 63 women with urinary incontinence (UI) and 51 healthy women (mean age: 52.54 ± 13.33 years). After revision, all I-CVIs and S-CVI/Ave were 1.00. EFA suggested a unidimensional structure in this sample, explaining 52% of variance, with loadings ≥0.598. PRAFAB-Turkish correlated strongly with UI scales (p < 0.001) and discriminated between groups (p < 0.001). Corrected item-total correlations exceeded 0.542. Internal consistency (Cronbach's α = 0.824) and test-retest reliability (ICC = 0.990) were good and excellent, respectively. Standard error of measurement (SEM), SEM%, minimum detectable change (MDC), and MDC% values were 0.372, 2.97%, 1.031, and 8.22%, respectively.
Findings support the validity and reliability of PRAFAB-Turkish for assessing UI-related quality of life.Trial registration: ClinicalTrials.gov, NCT07339657.

PMID:
42708641
Bibliographic data and abstract were imported from PubMed on 08 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement